Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

INVEST substudies: design and patient characteristics.

Clinical cardiology - 1 Nov 2001

Keltai M, Johnson J A, Kowey P R, Ried L D, Tueth M

Abstract excerpt

The INternational VErapamil SR/trandolapril STudy (INVEST) will provide a large database of information. Proposed substudies for analysis include ambulatory blood pressure monitoring (ABPM), depression, genotyping, atrial fibrillation, electrocardiogram (ECG), echocardiography, renal dysfunction, diabetes, and cardiac care cost estimate. This paper reviews the design and status of several of the INVEST...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Pressure Monitoring, Ambulatory
Share to Depression
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypertension

Source

Open in PubMed Open full text

Identifiers

PMID: 11712776
DOI: 10.1002/clc.4960241704
PMCID: PMC6655064

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

INVEST substudies: design and patient characteristics.PMID 11712776Read ↗

KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST).Semantic proximity Read ↗

Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension.Semantic proximity Read ↗

Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study.Semantic proximity Read ↗

Genetic evidence for T-wave area from 12-lead electrocardiograms to monitor cardiovascular diseases in patients taking diabetes medicationsSemantic proximity Read ↗

Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES).Semantic proximity Read ↗

Genetic evidence for T-wave area from 12-lead electrocardiograms to monitor cardiovascular diseases in patients taking diabetes medications.Semantic proximity Read ↗

G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.Semantic proximity Read ↗

CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response.Semantic proximity Read ↗

Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).Semantic proximity Read ↗

Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamil.Semantic proximity Read ↗

UMOD Genotype-Blinded Trial of Ambulatory Blood Pressure Response to Torasemide.Semantic proximity Read ↗

Empagliflozin's role in reducing ventricular repolarization heterogeneity: Insights into cardiovascular mortality decline from the EMPATHY-HEART trialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.